The Economics and Challenges of Breast Cancer in a Managed Care EnvironmentByBased on a presentation by Alan H. Heaton, PharmDJune 1st 1999
Medical and Economic Impact of Breast Cancer Treatment and PreventionByC. Alan Lyles, ScD, MPH, RPhJune 1st 1999
Benefits Foregone: Too Much of the Wrong and Too Little of the RightByBernard S. Bloom, PhDJune 1st 1999
Breast Cancer: Overview of Current Management Considerations of Economic ImpactBySandra E. Brooks, MDJune 1st 1999
Breast Cancer Stage Cost Analysis in a Managed Care PopulationByKenneth L. McDonough, MDJune 1st 1999
The Cost Effectiveness of Tamoxifen in the Prevention of Breast CancerByLes L. Noe, MPA, RPh,Russell V. Becker, III, MA,William J. Gradishar, MD,Mugdha Gore, PhD,Jeffrey P. Trotter, MMJune 1st 1999
